Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W LaFleur

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annual Review of Cancer Biology|August 22, 2022
CRISPR Screens to Identify Regulators of Tumor ImmunityMartin W LaFleur, Arlene H Sharpe
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2018
Inhibitors of the PD-1 Pathway in Tumor TherapyMartin W LaFleur, Yuki Muroyama, Charles G Drake, et al.
Cell Reports|September 19, 2019
T Cell Activation Depends on Extracellular AlanineNoga Ron-Harel, Jonathan M Ghergurovich, Giulia Notarangelo, et al.
The Journal of Experimental Medicine|March 18, 2017
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicityVikram R Juneja, Kathleen A McGuire, Robert T Manguso, et al.
Science Immunology|February 18, 2022
Batf-mediated epigenetic control of effector CD8<sup>+</sup> T cell differentiationHsiao-Wei Tsao, James Kaminski, Makoto Kurachi, et al.
Cell|July 21, 2021
Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathwayCharles L Evavold, Iva Hafner-Bratkovič, Pascal Devant, et al.
Nature Immunology|September 19, 2019
PTPN2 regulates the generation of exhausted CD8<sup>+</sup> T cell subpopulations and restrains tumor immunityMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Nature Communications|April 12, 2019
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune systemMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Cancer Immunology Research|December 5, 2020
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8<sup>+</sup> T CellsJefte M Drijvers, Jacob E Gillis, Tara Muijlwijk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2024
In Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector CellsMartin W LaFleur, Jasmin M D'Andrea, Dillon G Patterson, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annual Review of Cancer Biology|August 22, 2022
CRISPR Screens to Identify Regulators of Tumor ImmunityMartin W LaFleur, Arlene H Sharpe
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2018
Inhibitors of the PD-1 Pathway in Tumor TherapyMartin W LaFleur, Yuki Muroyama, Charles G Drake, et al.
Cell Reports|September 19, 2019
T Cell Activation Depends on Extracellular AlanineNoga Ron-Harel, Jonathan M Ghergurovich, Giulia Notarangelo, et al.
The Journal of Experimental Medicine|March 18, 2017
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicityVikram R Juneja, Kathleen A McGuire, Robert T Manguso, et al.
Science Immunology|February 18, 2022
Batf-mediated epigenetic control of effector CD8<sup>+</sup> T cell differentiationHsiao-Wei Tsao, James Kaminski, Makoto Kurachi, et al.
Cell|July 21, 2021
Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathwayCharles L Evavold, Iva Hafner-Bratkovič, Pascal Devant, et al.
Nature Immunology|September 19, 2019
PTPN2 regulates the generation of exhausted CD8<sup>+</sup> T cell subpopulations and restrains tumor immunityMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Nature Communications|April 12, 2019
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune systemMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Cancer Immunology Research|December 5, 2020
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8<sup>+</sup> T CellsJefte M Drijvers, Jacob E Gillis, Tara Muijlwijk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2024
In Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector CellsMartin W LaFleur, Jasmin M D'Andrea, Dillon G Patterson, et al.
Pageof 3